Early Detection of Lung Cancer With Laser-Induced Fluorescence Endoscopy and Spectrofluorometry

Yoko Kusunoki, Fumio Imamura, Hiroshi Uda, Masayuki Mano, Takeshi Horai
2000 Chest  
Study objectives: We performed a clinical trial of laser-induced fluorescence endoscopy (LIFE) for detection of precancerous lesions and cancer including carcinoma in situ (CIS), which are difficult to detect by white-light bronchoscopy. Design: Results with LIFE were compared with the criterion standard, white-light bronchoscopy. The evaluation of these endoscopic results spectrofluorometrically was examined, and pixels of LIFE images composed of digital signals for the intensities of red and
more » ... reen were analyzed. Setting: Tertiary-level hospital treating referrals and subjects with suspicious results in mass screening. Patients: We examined 65 subjects with suspected lung cancer by both methods, and performed biopsy on 216 lesions. Results: The accuracy of diagnosis by white-light bronchoscopy, with histopathologic results as the standard, was 48.6%. The accuracy by LIFE was 72.7%. The sensitivity of conventional bronchoscopy for detection of severe dysplasia (21 biopsy specimens) or cancer (28 biopsy specimens) was 61.2% and specificity was 85.0%. With results by LIFE added, these values were 89.8% and 78.4%, respectively. Of nine patients with CIS, only LIFE showed one lesion, and only LIFE showed the extent of seven of the lesions. The autofluorescence of eight lesions was measured spectrofluorometrically; normal bronchial tissue, severe dysplasia, and cancerous tissue had spectral differences. The red/green intensity of cancers on histograms of LIFE images generally was greater than the ratios for metaplasia or normal bronchial wall. Conclusions: Use of both methods should facilitate early detection. Evaluation by spectrofluorometry and analysis of digital signal intensity of results by LIFE make results more objective.
doi:10.1378/chest.118.6.1776 pmid:11115472 fatcat:55mcdn4mrzdtvony3jy55z7eny